Composition
- Active ingredients
- TISLELIZUMAB-JSGR 100MG/10ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TISLELIZUMAB-JSGR 100MG/10ML · InjectionThis page
- TISLELIZUMAB-JSGR 100MG/10ML(10MG/ML) · InjectableBLA761417-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761232.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tevimbra
- Active substance
- tislelizumab-jsgr
- Route
- Solution
- Dosage form
- Injection
- Applicant
- Beigene
- Status
- Prescription
- FDA approval
- 13 Mar 2024
- Application
- BLA761232-001